Skip to main content
Delfa

Lead sponsor

The Cleveland Clinic

7 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.

7

Trials led

4

Ongoing

515

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
1
Phase 4
5
Not applicable
1

Trials by status

Not yet recruiting
1
Recruiting
3
Completed
2
Terminated
1

Trials led

TIRO-AFBMI 27-60Ph 2Recruiting100
EMPOWER-T2DBMI ≥30Ph 4Terminated74
OPTIMALBMI 35-70Ph 4Recruiting70
TRANSITION-T2DHbA1c ≤7.5%Ph 4Completed60
Imaging in Semaglutide StudyBMI ≥30not applicableNot yet recruiting10